Biocon Current Share Price | Biocon Stock Screener
BIOCON
Pharmaceuticals
Biocon Current Stock Price Today
Live Share Price NSE
₹385.00
▲
5.00 (1.32%)
Live Share Price BSE
₹385.00
▲
5.00 (1.32%)
As of September 18, 2026, the live Biocon share price (NSE: BIOCON) is ₹385.00 on NSE and ₹385.00 on BSE, up 1.32% from the previous close, with shares trading between ₹379.30 and ₹388.00 in today's trading session, and a 52-week range of ₹339.00–₹440.70.
Browse BIOCON complete financial statements to support your investment research.
Use the Biocon stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Biocon Market Cap
₹63,320.76 Cr.
BIOCON P/E Ratio (TTM)
152.34
Biocon P/B Ratio
1.84
EPS (TTM)
₹2.82
Dividend Yield
0.13%
Debt to Equity
0.61
BIOCON 52 Week High
₹440.70
Biocon 52 Week Low
₹339.00
Operating Margin
20.00%
Profit Margin
4.39%
BIOCON Revenue (TTM)
₹4,537.00
EBITDA
₹960.00
Net Income
₹199.00
Total Assets
₹63,651.00
Total Equity
₹36,622.00
Biocon Current Share Price Chart
Track the current Biocon share price and stock price with an interactive chart. Analyse BIOCON price trends, trading volume, historical performance, and volatility across different timeframes — the complete Biocon stock quote in one place.
Biocon Company Profile - Fundamental Screener
Screen Biocon company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for BIOCON shares.
Biocon Limited is India's largest fully-integrated biopharmaceutical company, focusing on biotechnology products and research services. Founded in 1978, Biocon specializes in treating diabetes, cancer, and autoimmune diseases. The company develops and commercializes novel biologics, biosimilars, complex small molecule APIs, and generic formulations for global markets. Biocon's product portfolio includes cardiology,...more
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
Chairperson/CEO
Kiran Mazumdar Shaw
ISIN
INE376G01013
Website
https://www.biocon.com
Biocon Balance Sheet Screener
Screen BIOCON balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 63,651 | 58,797 | 56,071 | 52,043 | 20,394 | 18,522 | 14,444 | 12,192 | 9,990 | 9,394 |
| Current Assets | 17,180 | 16,286 | 15,179 | 12,334 | 8,382 | 7,600 | 5,325 | 4,889 | 4,149 | 4,048 |
| Fixed Assets | 36,486 | 31,963 | 30,644 | 29,468 | 6,569 | 6,364 | 5,971 | 4,471 | 3,700 | 3,626 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 12,960 | 16,751 | 15,437 | 21,043 | 7,096 | 5,805 | 3,053 | 2,447 | 2,200 | 2,502 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 36,622 | 27,713 | 25,275 | 22,489 | 9,470 | 8,508 | 7,383 | 6,707 | 5,649 | 5,214 |
| Share Capital | 811 | 600 | 600 | 600 | 600 | 600 | 600 | 300 | 300 | 100 |
| Reserves & Surplus | 33,329 | 21,122 | 19,183 | 17,267 | 7,832 | 7,027 | 6,106 | 5,798 | 4,881 | 4,738 |
Biocon Income Statement Screener - Profit & Revenue Analysis
Screen Biocon income statement and profit fundamentals.
Analyze BIOCON quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Biocon share price evaluation.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4,537 | 4,346 | 4,415 | 3,990 | 4,356 | 4,240 | 3,912 | 4,543 | 3,604 | 3,826 | 3,929 | 3,516 | 3,551 | 4,135 | 2,476 |
| Expenses | 3,577 | 3,502 | 3,339 | 3,193 | 3,472 | 3,633 | 3,013 | 2,813 | 2,905 | 3,070 | 2,820 | 2,741 | 2,769 | 3,051 | 1,911 |
| EBITDA | 960 | 844 | 1,077 | 797 | 884 | 607 | 900 | 1,730 | 699 | 756 | 1,109 | 775 | 782 | 1,084 | 565 |
| Operating Profit % | 20.00% | 18.00% | 23.00% | 18.00% | 19.00% | 12.00% | 22.00% | 17.00% | 18.00% | 19.00% | 25.00% | 20.00% | 18.00% | 14.00% | 21.00% |
| Depreciation | 513 | 547 | 436 | 455 | 473 | 515 | 407 | 405 | 420 | 425 | 364 | 358 | 389 | 415 | 212 |
| Interest | 232 | 213 | 212 | 277 | 272 | 210 | 227 | 236 | 226 | 223 | 249 | 233 | 248 | 267 | 11 |
| Profit Before Tax | 248 | 128 | 487 | 97 | 171 | -68 | 319 | 1,146 | 98 | 156 | 497 | 184 | 214 | 808 | 343 |
| Tax | 49 | -9 | 27 | 8 | 39 | -16 | 96 | 284 | 71 | 75 | 82 | 35 | 42 | 55 | 59 |
| Net Profit | 199 | 137 | 459 | 89 | 133 | -52 | 223 | 862 | 27 | 81 | 415 | 149 | 173 | 753 | 284 |
| EPS | 0.79 | 0.87 | 2.88 | 0.26 | 0.66 | 1.08 | 1.13 | 5.51 | -0.13 | 0.21 | 2.62 | 0.85 | 1.05 | 5.52 | 2.00 |
Biocon Cash Flow Screener - Liquidity Fundamentals
Screen BIOCON cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 1,994 | 4,061 | 2,954 | 1,853 | 1,177 | 1,160 | 1,283 | 1,155 | 662 | 640 |
| Investing Activities | -1,883 | -203 | -1,002 | -14,260 | -1,662 | -3,651 | -1,505 | -703 | -684 | -510 |
| Financing Activities | -924 | -1,854 | -2,333 | 13,049 | 242 | 2,564 | 388 | -242 | -240 | -178 |
| Net Cash Flow | -812 | 2,004 | -380 | 641 | -243 | 72 | 165 | 210 | -261 | -47 |
Biocon Shareholding Pattern Screener
See Biocon shareholding pattern with promoter, FII, and DII holdings.
Check Biocon promoter holding and ownership changes for BIOCON on TickJournal.
| Item | 2026-Jan | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 44.91% | 44.91% | 44.68% | 60.64% | 54.45% | 54.45% | 54.45% | 60.64% |
| FII Holding | 7.14% | 7.52% | 8.14% | 5.66% | 6.04% | 6.61% | 7.39% | 5.63% |
| DII Holding | 24.16% | 24.07% | 23.38% | 15.72% | 22.82% | 22.10% | 21.71% | 13.68% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 10.23% | 10.01% | 10.26% | 13.63% | 12.58% | 12.71% | 12.38% | 15.53% |
| Other Holding | 13.55% | 13.49% | 13.54% | 4.34% | 4.10% | 4.12% | 4.06% | 4.52% |
| Shareholder Count | 394,215 | 386,593 | 392,509 | 424,297 | 430,217 | 413,191 | 394,279 | 470,261 |
Biocon Share Dividend Screener - Share Yield Analysis
Check Biocon dividend history with payout and yield data.
View Biocon dividend details including ex-dates and amounts for BIOCON stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.50 | 0.13% |
| 2025-March | ₹0.50 | 0.14% |
| 2024-March | ₹0.50 | 0.15% |
| 2023-March | ₹1.50 | 0.57% |
| 2022-March | ₹0.50 | 0.25% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹1.00 | 0.37% |
| 2018-March | ₹1.00 | 0.33% |
| 2017-March | ₹3.00 | 1.01% |
Biocon Stock Index Membership
See which indices include Biocon stock.
Check BIOCON index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE 1000
BSE 200 EQUAL WEIGHT
BSE INDEX BSE HC
BSE INDEX BSE200
BSE INDEX BSE500
BSE INDEX LMI250
BSE INDEX MID150
BSE INDEX MIDCAP
BSE INDEX MSL400
NIFTY 200
NIFTY 500
NIFTY HEALTHCARE
NIFTY LARGEMID250
NIFTY MIDCAP 100
NIFTY MIDCAP 150
NIFTY MIDSML 400
NIFTY MIDSML HLTH
NIFTY PHARMA
NIFTY TOTAL MKT
NIFTY500 EQUAL WEIGHT
NIFTY500 LARGEMIDSMALL EQUAL CAP WEIGHTED
NIFTY500 MULTICAP
NIFTYM150MOMNTM50
Biocon Market Events Screener - Corporate Actions
Get Biocon corporate actions including splits, bonuses, and buybacks.
Check Biocon stock events that may affect BIOCON share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-12-31 | 2026-12-31 | Extraordinary General Meeting | NA | -0.61% |
| 2026-08-06 | 2026-08-06 | Annual General Meeting | NA | 2.33% |
| 2026-08-05 | 2026-08-05 | Quarterly Result Announcement | NA | -2.50% |
| 2026-07-03 | 2026-07-03 | Dividend | ₹ 0.50 /share | 9.94% |
| 2026-05-07 | 2026-05-07 | Quarterly Result Announcement | NA | 6.41% |
| 2026-02-12 | 2026-02-12 | Quarterly Result Announcement | NA | 1.08% |
| 2025-11-11 | 2025-11-11 | Quarterly Result Announcement | NA | 8.49% |
| 2025-08-08 | 2025-08-08 | Annual General Meeting | NA | 5.11% |
| 2025-08-07 | 2025-08-07 | Quarterly Result Announcement | NA | -3.08% |
| 2025-07-04 | 2025-07-04 | Dividend | ₹ 0.50 /share | 8.05% |
| 2025-05-08 | 2025-05-08 | Quarterly Result Announcement | NA | 2.18% |
| 2025-01-30 | 2025-01-30 | Quarterly Result Announcement | NA | -4.63% |
| 2024-10-30 | 2024-10-30 | Quarterly Result Announcement | NA | -11.82% |
| 2024-08-09 | 2024-08-09 | Annual General Meeting | NA | 8.75% |
| 2024-07-05 | 2024-07-05 | Dividend | ₹ 0.50 /share | 15.77% |
Biocon Competitors Screener - Peer Comparison
Screen BIOCON competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 441,478 | 36.91 | 61,674 | 12.69% | 11,565 | 34.00 |
| Divis Laboratories | 247,470 | 85.36 | 11,067 | 13.95% | 2,568 | 63.65 |
| Torrent Pharmaceuticals | 188,872 | 86.95 | 13,886 | 20.34% | 2,138 | 52.16 |
| Zydus Life Science | 112,608 | 24.28 | 27,658 | 17.64% | 5,026 | 45.64 |
| Cipla | 110,352 | 33.22 | 29,045 | 2.24% | 3,870 | 35.27 |
| Laurus Labs | 106,298 | 95.94 | 6,868 | 22.01% | 890 | 68.28 |
| Dr Reddys Laboratories | 97,281 | 29.91 | 35,059 | 3.90% | 4,158 | 47.72 |
| Aurobindo Pharma | 96,652 | 25.88 | 34,145 | 5.56% | 3,503 | 57.04 |
| Lupin | 95,790 | 17.09 | 29,039 | 26.75% | 5,356 | 28.17 |
| Mankind Pharma | 94,163 | 44.87 | 14,636 | 14.85% | 1,938 | 37.57 |
Biocon Company Announcements - News Screener
Screen BIOCON latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-09-13 | Communication Regarding Remittance Of Final Dividend For The FY 2025-26 | - |
| 2026-09-12 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-09-12 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-08-31 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-08-28 | Communication Regarding Remittance Of Final Dividend For The FY 2025-26 | - |
| 2026-08-26 | Revised Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-08-25 | Company Statement | - |
| 2026-08-18 | Company Statement | - |
| 2026-08-11 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-08-11 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | - |
| 2026-08-08 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2026-08-07 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-08-07 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-06 | Announcement under Regulation 30 (LODR)-Resignation of Statutory Auditors | - |
| 2026-08-06 | Announcement under Regulation 30 (LODR)-Change in Directorate | - |
| 2026-08-06 | Completion Of Tenure Of Statutory Auditors | - |
| 2026-08-06 | Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s | - |
| 2026-08-06 | Announcement under Regulation 30 (LODR)-Change in Directorate | - |
| 2026-08-06 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2026-08-06 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |